RALLYBIO CORPORATION Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
RALLYBIO CORPORATION (RLYB) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $169.32 million as of 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Equity
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-03-06
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $169.32M.
- 2022-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $131.94M.
- 2022-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $147.85M.
- 2022-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $163.04M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2022-12-31 | $169.32M 10-K · filed 2023-03-06 |
| 2022-09-30 | $131.94M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $147.85M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $163.04M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $175.60M 10-K · filed 2023-03-06 |
| 2021-09-30 | $186.49M 10-Q · filed 2021-11-10 |
| 2020-12-31 | $136.00M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |